Financial Performance - The company's revenue for Q1 2025 was CNY 625,145,364.48, representing a 20.35% increase compared to CNY 519,450,050.36 in the same period last year[4]. - Net profit attributable to shareholders was CNY 51,116,537.85, up 13.23% from CNY 45,143,153.81 year-on-year[4]. - Basic and diluted earnings per share increased by 14.53% to CNY 0.0662, compared to CNY 0.0578 in the same period last year[4]. - Net profit for the current period was ¥51,782,589.64, representing a 9.3% increase from ¥47,574,039.07 in the previous period[23]. - Earnings per share (EPS) for the current period was ¥0.0662, compared to ¥0.0578 in the previous period, reflecting a growth of 14.9%[23]. - The company reported a total comprehensive income of ¥50,939,813.63 for the current period, compared to ¥46,785,956.65 in the previous period, an increase of 8.6%[23]. Cash Flow - The net cash flow from operating activities decreased by 21.22% to CNY 57,819,950.74, down from CNY 73,390,050.46 in the previous year[4]. - Operating cash flow for the current period is ¥57,819,950.74, a decrease of 21.2% from ¥73,390,050.46 in the previous period[24]. - Total cash inflow from operating activities is ¥593,282,261.11, compared to ¥571,501,441.52 in the previous period, reflecting a growth of 3.1%[24]. - Cash outflow from operating activities increased to ¥535,462,310.37 from ¥498,111,391.06, representing a rise of 7.5%[24]. - Investment activities generated a net cash flow of -¥67,865,040.40, an improvement from -¥83,274,179.55 in the previous period[24]. - Net cash flow from financing activities decreased by CNY 105,384,328.70, a decline of 95.27%, as operating cash flow was sufficient to meet the company's normal operational needs, reducing bank borrowings[13]. - Net cash flow from financing activities was ¥5,230,846.58, significantly lower than ¥110,615,175.28 in the previous period, a decline of 95.3%[25]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 5,682,049,224.10, a slight increase of 0.56% from CNY 5,650,587,583.04 at the end of the previous year[4]. - Total assets as of the end of the current period were ¥5,682,049,224.10, slightly up from ¥5,650,587,583.04 in the previous period[21]. - Total liabilities decreased to ¥3,123,997,855.14 from ¥3,150,724,813.22, indicating a reduction of 0.8%[21]. - The total equity attributable to shareholders of the parent company increased to ¥2,303,056,809.68 from ¥2,246,607,845.93, marking a growth of 2.5%[21]. Expenses - Total operating costs amounted to ¥569,770,727.13, up 21.3% from ¥469,749,153.26 in the prior period[22]. - Management expenses increased by 49.28% to CNY 25,664,246.52, mainly due to salary adjustments and legal fees for tax refund assistance[7]. - Research and development expenses for the current period were ¥22,598,102.58, up from ¥19,538,556.28, reflecting an increase of 10.5%[22]. Investments - Investment income rose by 118.04% to CNY 571,820.19, mainly from interest on debt investments by a subsidiary[8]. - The company reported a decrease in long-term equity investments to CNY 259,204.80 from CNY 259,573.12, suggesting stability in investment holdings[19]. - The company received ¥1,200,000.00 from minority shareholders as part of investment activities[24]. - Cash received from other financing activities increased to ¥63,184,715.90 from ¥50,000,000.00, a growth of 26.4%[25]. Shareholder Information - Total number of common shareholders at the end of the reporting period was 31,569, with no preferred shareholders[15]. - The largest shareholder, Inner Mongolia Jinhe Holdings Co., Ltd., holds 31.33% of shares, totaling 241,758,670 shares[15]. Inventory and Receivables - Accounts receivable increased to CNY 543,379,584.90 from CNY 498,611,653.92, indicating a rise in credit sales[19]. - Inventory at the end of the reporting period was CNY 666,182,132.79, up from CNY 635,279,943.82, reflecting increased stock levels[19]. Other Financial Metrics - The company reported a significant increase in prepayments, which rose by 159.60% to CNY 28,284,968.40, primarily to ensure sufficient supply of raw materials[6]. - The company experienced a 60.92% increase in taxes and surcharges, amounting to CNY 2,227,076.54, attributed to improved operational performance[7]. - The company reported a 51.13% decrease in tax refunds received, totaling CNY 15,891,497.15, due to the absence of customs duty refunds this period[11]. - Deferred income tax assets decreased to ¥51,963,930.59 from ¥71,211,031.61, a decline of 26.9%[20]. Audit Information - The company did not undergo an audit for the first quarter report[26].
金河生物(002688) - 2025 Q1 - 季度财报